Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome

被引：21

作者：

Strupp, C

Hildebrandt, B

Germing, U

Haas, R

Gattermann, N

机构：

[1] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany

[2] Univ Dusseldorf, Dept Human Genet, D-4000 Dusseldorf, Germany

来源：

LEUKEMIA | 2003年 / 17卷 / 06期

关键词：

D O I：

10.1038/sj.leu.2402894

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1200 / 1202

页数：4

共 8 条

[1]

BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x

[2] Thalidomide in agnogenic and secondary myelofibrosis [J].

Canepa, L ;

Ballerini, F ;

Varaldo, R ;

Quintino, S ;

Reni, L ;

Clavio, M ;

Miglino, M ;

Pierri, I ;

Gobbi, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) :313-315

[3]

Cheson BD, 2000, BLOOD, V96, P3671

[4] International scoring system for evaluating prognosis in myelodysplastic syndromes [J].

Greenberg, P ;

Cox, C ;

LeBeau, MM ;

Fenaux, P ;

Morel, P ;

Sanz, G ;

Sanz, M ;

Vallespi, T ;

Hamblin, T ;

Oscier, D ;

Ohyashiki, K ;

Toyama, K ;

Aul, C ;

Mufti, G ;

Bennett, J .

BLOOD, 1997, 89 (06) :2079-2088

[5] Thalidomide and its analogues have distinct and opposing effects on TNF-α and TNFR2 during co-stimulation of both CD4+ and CD8+ T cells [J].

Marriott, JB ;

Clarke, IA ;

Dredge, K ;

Muller, G ;

Stirling, D ;

Dalgleish, AG .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (01) :75-84

[6] Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes [J].

Raza, A ;

Meyer, P ;

Dutt, D ;

Zorat, F ;

Lisak, L ;

Nascimben, F ;

du Randt, M ;

Kaspar, C ;

Goldberg, C ;

Loew, J ;

Dar, S ;

Gezer, S ;

Venugopal, P ;

Zeldis, J .

BLOOD, 2001, 98 (04) :958-965

[7] Thalidomide for the treatment of patients with myelodysplastic syndromes [J].

Strupp, C ;

Germing, U ;

Aivado, M ;

Misgeld, E ;

Haas, R ;

Gattermann, N .

LEUKEMIA, 2002, 16 (01) :1-6

[8] The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes [J].

Zorat, F ;

Shetty, V ;

Dutt, D ;

Lisak, L ;

Nascimben, F ;

Allampallam, K ;

Dar, S ;

York, A ;

Gezer, S ;

Venugopal, P ;

Raza, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) :881-894

← 1 →